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The purpose of the present study was to ﬁnd out whether co-treatment of human neutrophils with high
glucose and methylglyoxal (MGO) can alter the biochemical parameters of human neutrophils. We also
examined if astaxanthin associated with vitamin C can improve those biochemical parameters. Neutro-
phils from healthy subjects were treated with 20 mM of glucose and 30 lM MGO followed or not by
the addition of the antioxidants astaxanthin (2 lM) and vitamin C (100 lM). MGO/high glucose treat-
ment reduced the phagocytic capacity and the G6PDH, total/SOD and GR activities. Additionally, there
was an increase in the activity of myeloperoxidase (MPO) with consequent increase in the hypochlorous
acid production, CAT activity and in the release of IL-6 cytokine without changes in intracellular calcium
mobilization. Our study also shows that the association of astaxanthin with vitamin C greatly improved
neutrophil phagocytic capacity, decreasing all reactive oxygen species measured, pro-inﬂammatory IL-1b
and TNF-a release, MPO activity and HClO production. The combination of astaxanthin with vitamin C
alone has more antioxidant and anti-inﬂammatory effects than when they were in the presence of
MGO/high glucose. Injury to the function of neutrophils due to high glucose and methylglyoxal appears
not to involve oxidative stress or calcium release. The association of antioxidants astaxanthin and vitamin
C promoted a signiﬁcant improvement in the function of neutrophils and in the redox status.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Methylglyoxal (MGO), a highly reactive dicarbonyl metabolite
produced during glucose metabolism, is a major precursor of the
advanced glycation end products (AGEs). AGEs are the result of
the non-enzymatic glycation of proteins/lipids which accumulate
during natural aging. In general, they are also greatly augmented
in disorders such as diabetes, renal failure and Alzheimer’s disease
(Brownlee, 1995; Schmidt et al., 1994; Takedo et al., 1996). MGO
clinical signiﬁcance is based on the fact that there is a strong asso-
ciation between the pathophysiology of type 2 diabetes along with
associated vascular and neuronal complications, and increased
plasma MGO and AGEs concentrations (Turk, 2010). Dhar et al.
(2008) showed that vascular smooth muscle cells treated with high
glucose (25 mM) increased intracellular MGO concentration
accompanied by increased oxidative stress. Both MGO and high
glucose may activate different pathways, increasing reactive spe-
cies of oxygen and nitrogen production (ROS/RNS) which in turn,
leads to oxidative stress (Wang et al., 2009). AGEs formed from, 1295, 03342000 São Paulo,
sul.edu.br, rosemariotton@
sevier OA license.high glucose and/or MGO can also link to speciﬁc AGE-receptor
(RAGE) present in the plasma membrane of different cell types,
including immune cells, and trigger inﬂammatory response by
increasing activation of NFjB signaling pathway (Kalapos, 1999).
Immune cell dysfunction is a common feature involved in the
pathogenesis and/or late complications of several chronic diseases.
Phagocytosis and killing of the pathogens are the primary functions
of neutrophils in the innate immune response in order to contain
and kill invading microbial pathogens. This process is achieved
through a series of rapid and coordinated responses (Fialkow
et al., 2007). Neutrophils exhibit a potent antimicrobial arsenal that
includes oxidants, proteinases, and antimicrobial peptides. Neutro-
phils also produce prodigious quantities of ROS and RNS such as
superoxide and nitric oxide through the activity of oxidant-
generating systems such as the phagocyte NADPH oxidase
(Sheppard et al., 2005) and nitric oxide synthase (NOS), respectively
(Fialkow et al., 2007; Gebska et al., 2005; Kleinert et al., 2004).
Astaxanthin (ASTA) is an orange-reddish carotenoid pigment
found in living organisms particularly in the marine environment
where it is present in microalgae, plankton, krill and seafood. It
gives salmon, trout, and crustaceans such as shrimp and lobster
their distinctive pinkish coloration (Fassett and Coombes, 2011).
ASTA belongs to the xanthophyll class of carotenoids and is closely
related to b-carotene, lutein, lycopene, and zeaxanthin, sharing
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noids (Yuan et al., 2011). Several studies have demonstrated that
astaxanthin exhibits a wide variety of biological activities, includ-
ing the prevention and treatment of various diseases, such as
cancers, chronic inﬂammatory diseases, metabolic syndrome, dia-
betes, diabetic nephropathy, cardiovascular diseases, gastrointesti-
nal diseases, liver diseases, and neurodegenerative diseases (Chew
et al., 1999; Jyonouchi et al., 2000; Kishimoto et al., 2010; Marin
et al., 2011; Naguib, 2000; Otton et al., 2011).
The presence of the hydroxyl and keto moieties on each ionone
ring (Fig. 1) explains some of its unique features such as the ability
to be esteriﬁed, a higher antioxidant activity, and a more polar nat-
ure than other carotenoids (Hussein et al., 2006). Astaxanthin may
act as a strong antioxidant by donating the electrons and reacting
with free radicals to convert them into more stable products and
terminate free radical chain reaction in a wide variety of living
organisms. The nonpolar middle segment of the astaxanthin mole-
cule is a series of carbon-carbon double bonds, which alternatewith
carbon-carbon single bonds, termed ‘‘conjugated’’. This polar-
nonpolar-polar layout also allows the astaxanthin molecule to take
a transmembrane orientation, making a precise ﬁt into the polar-
nonpolar-polar span of the cell membrane (Kidd, 2011). As men-
tioned by many authors, the antioxidant activity of astaxanthin ap-
pears to be greater than that of beta-carotene and alpha-tocopherol
(Fukuzawa et al., 1998; Naguib, 2000). However, studies from our
group which evaluated the antioxidant effect of astaxanthin on leu-
kocytes in human and animalmodels, showed amodest antioxidant
action (Bolin et al., 2010; Guerra and Otton, 2011; Macedo et al.,
2010; Mattei et al., 2011; Otton et al., 2010, 2011), mainly observed
in the reduction of superoxide and hydrogen peroxide production.
Vitamin C is an essential micronutrient, which has been impli-
cated in a variety of biological processes, including immune re-
sponse (Maeng et al., 2009). Vitamin C or L-ascorbic acid is the
body’s most important intracellular and extracellular aqueous-
phase antioxidant. This antioxidant easily scavengers peroxyl radi-
cals, superoxide anion, singlet oxygen and hypochlorite (Sies and
Stahl, 1995). The oxidation of vitamin C by reacting with ROS gen-
erates the ascorbyl radical that has little reactivity, crucial to the
antioxidant effect of vitamin C. Ascorbic acid is considered a phys-
iological substrate for myeloperoxidase (MPO) and its effect on
myeloperoxidase-dependent processes is widely attributed to scav-
enger or quencher actions on hypochlorous acid (Myzak and Carr,
2002; Savenkova et al., 1994). Polymorphonuclear cells such as
neutrophils present millimolar concentrations of ascorbic acid in
their cytosol which can be understood as an important protective
role against the action of reactive species produced by neutrophils
(Guaiquil et al., 2001; Wang et al., 1997). Deﬁciency of this vitamin
is associated with impaired function of this cell type, including the
reduction of its antimicrobial activity (Goldschmidt, 1991) and de-
creased spontaneous apoptosis (Vissers and Wilkie, 2007). Because
both antioxidants are present in speciﬁc microenvironment in cells
compartments, we believe that a combination of astaxanthin with
vitamin C can improve the antioxidant effect of both.Fig. 1. Chemical structuThe purpose of the present study was to ﬁnd out whether co-
treatment of human neutrophils with high glucose (20 mM) and
MGO can alter the biochemical parameters of these immune cells.
High glucose was used as a physiological intracellular source of
MGO as previously described (Dhar et al., 2008). We also examined
if astaxanthin associated with vitamin C can improve those bio-
chemical parameters. In addition, we evaluated the mechanism
underlying this modulation.
2. Materials and methods
2.1. Reagents
Methylglyoxal, D-glucose, astaxanthin, dihydroethidium, vita-
min C, propidium iodide and most of the other chemicals were
purchased from Sigma-Aldrich Chemical Company (St. Louis, MO,
USA), except RPMI-1640 culture medium, lucigenin and pluronic
acid, and acetoxymethylester (Fura-2AM), which came from Invit-
rogen (CA, USA). Common reagents for buffers (e.g. PBS) and regu-
lar laboratory solutions were obtained from Labsynth (Diadema,
SP, Brazil).
2.2. Subjects
The Ethical Committee of the Universidade Cruzeiro do Sul ap-
proved the experimental procedure of this study. Around 30
healthy adult women and men (mean age 21.0 ± 4.0) were in-
cluded in the present study. The subjects recruited did not present
any systemic or topical therapeutic regimen, a smoking history,
alcohol habits, obesity or any other systemic diseases at least for
the last 2 months (based on an anamnesis protocol).
2.3. Cell isolation and culture condition
Neutrophils were obtained through the collection of human
peripheral blood by venipuncture procedure in vacuum/siliconized
tubes containing 0.1 mM EDTA. Peripheral blood neutrophils were
isolated under sterile conditions by using a density gradient present
in the reagent Histopaque 1077 (Sigma–Aldrich), according to the
manufacturer’s instruction. After obtained, neutrophils were
counted in aNeubauer chamber using Trypan blue (1%). Neutrophils
(1  106/mL) from each volunteer were cultured in 1 mL of RPMI-
1640 medium supplemented with 10% fetal bovine serum, 20 mM
Hepes, 2 mM glutamine, and antibiotics (streptomycin 100 units/
mL and penicillin 200 units/mL) or ressuspended in Tyrode’s solu-
tion (137 mM NaCl, 2.68 mM KCl, 0.49 mMMgCl2, 12 mM NaHCO3,
0.36 mM NaH2PO4, 5.6 mM D-glucose, and 5 mM acid HEPES, pH
7.4) for acute assays.
Before starting our experiments we evaluated the toxicity of
increasing concentrations of MGO on neutrophils. For this purpose,
cells (2.5  105) were treated for 18 h with MGO in concentrations
ranging from 1 to 500 lM. After this period the cells were collected
and analyzed by Trypan blue exclusion. In the literature, there of astaxanthin.
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levels can be 5–6 times higher in patients with diabetes types 1
and 2 (Dutra et al., 2005). Based on those data, the concentration
of MGO selected to be used in the present study was 30 lM
MGO (nontoxic, data not shown) in Tyrode’s solution. Glucose
concentration was used at 20 mM, also conﬁrmed as a nontoxic
concentration (Trypan blue exclusion, data not shown). Astaxan-
thin at 2 lM was solubilized in DMSO, whereas vitamin C at
100 lM was solubilized in Tyrode’s solution. The following exper-
imental groups were created: control (without treatment), AV
(astaxanthin + vitamin C), GM (glucose + methylglyoxal) and
AVGM (astaxanthin + vitamin C + glucose + methylglyoxal). Cells
were cultured at 5% CO2 for 18 h at 37 C and then were collected,
centrifuged and stored at 80 C to assay glutathione content and
antioxidant enzyme activity. To measure cytokines release, cells
were cultured for 18 h and the supernatant was collected and
stored under the same condition. ROS production and phagocytic
capacity were assayed in neutrophils after acute treatment of cells.
2.4. Cell membrane integrity
To assess whether the concentration of MGO, glucose and both
antioxidants astaxanthin and vitamin C selected for the experi-
ments caused toxicity in neutrophils, we assayed cell viability by
using ﬂow cytometer analysis. Immediately after being obtained
and at the end of the culture period (24 h), cells (5  105) were
treated as previously described and then used to test the mem-
brane integrity. This assay was carried out in a FACScalibur ﬂow
cytometer (Becton Dickinson, Mountain View, CA) using propidium
iodide (PI) (50 lg/mL) dissolved in phosphate buffered saline
(0.137 M NaCl, 2.7 mM KCl, 8.0 mM Na2HPO4, pH 7.4). PI is a highly
water-soluble ﬂuorescent compound that cannot pass through in-
tact membranes and is generally excluded from viable cells. When
cells lose membrane integrity it passes through membrane and
binds to DNA. Therefore, an increase in ﬂuorescence to PI indicates
a decrease in the proportion of viable cells. Fluorescence of PI was
determined in FL2 channel (orange-red ﬂuorescence-585/42 nm).
The results were expressed as percentage of the control group.
2.5. Neutrophil functional parameters
2.5.1. Phagocytic capacity
Neutrophils (5  105 cell/well) were treated and incubated for
60 min at 37 C in 1 mL RPMI 1640 medium with opsonised zymo-
san particles. Zymosan particles (5  106/well) were opsonized by
incubation in the presence of control serum for 60 min. Afterwards
cells were harvested, citocentrifuged, stained and counted in an
optical microscope. The score of phagocytosis was expressed by
the number of cells that had one, two, three, four or more phago-
cyted zymosan particles (Sampaio et al., 2001).
2.5.2. Measurement of hypochlorous acid (HOCl) production
Production of HOCl by neutrophils was evaluated according to
the method described by Dypbukt et al. (Dypbukt et al., 2005). In
short, after treatment neutrophils (6  105/well) were stimulated
with phorbol myristate acetate (PMA) (60 ng/well) for 60 minutes.
The reaction was performed in a modiﬁed PBS (NaCl 140 mM, KCl
10 mM, MgCl2 0.5 mM, CaCl2 1 mM, glucose 1 mg/mL and taurine
5 mM), pH 7.4. Reactions were stopped by the addition of
26.8 units/mL of catalase. Cells were then centrifuged, the superna-
tant (200 lL) was collected and added with 50 lL of solution con-
taining 2 mM of 3,30,5,50-tetramethylbenzidine (TMB), 100 lM
sodium iodide, and 10% dimethylformamide in 400 mM acetate
buffer. After 5 min, absorbance was recorded at 650 nm in a micro-
plate reader and a standard curve (1–40 lM of HOCl) was used to
determine the concentration of hypochlorous acid.2.5.3. Measurement of myeloperoxidase (MPO) release from
neutrophils
ThemeasurementofMPOenzymeactivitywasperformedbyoxi-
dation of luminol in the presence of H2O2 and PMA according to
Hatanaka et al. (2006). Neutrophils (2  106 cells/well) were ex-
posed for 30 min, at 37 C, with or without 2 lM of astaxanthin;
100 lM of vitamin C and/or 20 mM of glucose, and 30 lM of MGO
in the presence or absence of PMA. After incubation, the medium
was immersed into ice and centrifuged at 500g for 10 min, at 4 C,
to separate the supernatant fromthe cells. The supernatantwasused
tomeasureMPOactivity. The reactionwas run inPBS,H2O2 (0.1 mM)
and luminol (1 mM), at 37 C, in a ﬁnal volume of 300 lL. Chemilu-
minescence was determined in a microplate reader. Results are ex-
pressed as relative luminescence unit (RLU) of degranulation.
2.5.4. Glucose-6-phosphate dehydrogenase (G6PDH) activity
Glucose-6-phosphate dehydrogenase (G6PDH), EC 1.1.l.49, is a
key regulatory enzyme of the oxidative segment of the pentose-
phosphate pathway. It produces equivalent reducing agents in
the form of NADPH to meet some cellular needs for reductive bio-
synthesis and as a contribution to the maintenance of the cellular
redox state (Costa Rosa et al., 1995). The maximum activity of this
enzyme was previously described (Guerra and Otton, 2011). The
extraction buffer consisted of Tris-HCl (50 mM), EDTA (1 mM) at
pH 8.0. The reaction buffer used contained Tris-HCl (86 mM),
MgCl2 (6.9 mM), NADP+(0.4 mM), glucose-6-phosphate (1.2 mM)
and Triton X-100 0.05% (v/v) at pH 7.6. The total volume of the
sample was 374 lL. The reaction was started by adding glucose-
6-phosphate to the medium. The absorbance at 340 nm was ana-
lyzed in a microplate reader (Tecan, Salzburg, Austria), and the re-
sults are expressed as nmol/min/mg of protein.
2.5.5. Release of pro-inﬂammatory cytokines
Cytokines IL-6, IL-1b and TNF-a were assayed in cell culture
supernatant with ELISA kits according to the manufacturer’s
instructions (Quantikine, R&D System, Minneapolis, MN, USA).
Neutrophils (1  106/mL) were cultured for 18 h in the presence
or absence of LPS as a stimulus (10 lg/mL). Afterwards, cells were
centrifuged (1000g, 4 C, 10 min) and the supernatant was col-
lected and stored at 80 C until they are used for cytokines deter-
mination. The lower limits of detection for the ELISA analyses were
as follows: 1.17 pg/mL for IL-6 and 1.95 pg/mL for IL1-b and TNF-a.
2.6. Oxidative parameters
2.6.1. Dihydroethidium assay
Dihydroethidium (DHE) is a ﬂuorescent probe used to measure
intracellular superoxide anion production. Once inside the cell,
DHE is rapidly oxidized to ethidium (a red ﬂuorescent compound)
by superoxide and/or H2O2 (in the presence of peroxidase). Neutro-
phils (5  105/well) were incubated with 5 lM DHE for 15 min at
room temperature in the dark. Afterwards, the cells were treated
and stimulated with PMA (20 ng/well). As a internal control, cells
were treated with either 10 lM DPI or 5 lM rotenone (a complex
1 – electron transport chain inhibitor), and 0.4 mM sodium azide
(SA), a complex III – electron transport chain inhibitor for 30 min
prior to treatment. Also, to ensure the speciﬁcity of DHE to super-
oxide anion, hydrogen peroxide (50 lM) was added to control-
PMA stimulated cells. The ﬂuorescence was analyzed in a micro-
plate reader (Tecan, Salzburg, Austria) (396 nm wavelength excita-
tion and 590 nmwavelength emission). The results were expressed
as percentage of the control group.
2.6.2. Lucigenin
The lucigenin chemiluminescent probe was utilized to measure
the extracellular superoxide anion content mainly produced
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form of light after excitation by superoxide anion. The chemilumi-
nescenceproducedwasmonitoredbya luminometer for60 min (Te-
can, Salzburg,Austria). Lucigenin (5 lM)wasadded to cells (5  105/
well) treated with or without 20 mM of glucose and 30 lMof MGO,
in thepresenceor absenceof 2 lMofastaxanthin, 100 lMofvitamin
C in Tyrode’s buffer supplemented with fetal bovine serum 1%. The
experiments were carried out in triplicate in the presence and ab-
sence of opsonized zymosan particles (1  106/well) used as a
ROS-inducer. As internal control, 10 lM diphenyleneiodonium
(DPI), a NADPH-oxidase inhibitor, or 0.4 mM sodium azide (SA), a
complex III – electron transport chain inhibitor, were added to con-
trol cells 30 min prior to the lucigenin evaluation. Results are ex-
pressed as chemiluminescence relative units. The statistical
analysis was performed by AUC calculation (area under the curve)
of at least three different experiments performed in triplicate.
2.6.3. Hydrogen peroxide production by phenol red assay
Hydrogenperoxide (H2O2) productionwasmeasured according to
Pick and Mizel (1981), based on horseradish peroxidase, which cata-
lyzes the phenol red oxidation by H2O2. Neutrophils (5 105/well)
were incubatedwith orwithout 2 lMof astaxanthin, 100 lMof vita-
min C and 20 mM of glucose, and 30 lM of MGO in Tyrode’s buffer,
mixed with 0.28 mM phenol red and horseradish peroxidase
(1,000 units/mg) at 37 C for 1 h. The production of H2O2 was
measured in the absence and presence of PMA (20 ng/well). The
reactionwas terminated by alkalinization (addition of 10 lL of NaOH
1M solution) and absorbance at 620 nm was measured to evaluate
H2O2 concentration (compared to a standard curve). The resultswere
expressed as percentage of the control group.
2.6.4. General ROS production assayed by DCFH-DA
The probe DCFH-DA is primarily used as an indicator of the pro-
duction of H2O2 (Brandt and Keston, 1965) but it is also described
as being oxidized by other ROS such as HO., ROO., NO and perox-
ynitrite (Crow, 1997). The cells (5  105/well) were preloaded with
DCFH-DA (5 lM) by incubation in culture medium for 30 minutes.
DCFH-DA is cleaved inside the cells by non speciﬁc esterase and
turns to high ﬂuorescent 2,7-dichloroﬂuoroscein (DCF) upon oxi-
dation by ROS. After the loading period, cells were treated with
or without 2 lM of astaxanthin, 100 lM of vitamin C and 20 mM
of glucose, and 30 lM of MGO in Tyrode’s buffer for 60 minutes.
The experiments were conducted in the presence or absence of
PMA (20 ng/well). Afterwards, cells were centrifuged and resus-
pended in 300 lL of Tyrode´s buffer, and the ﬂuorescence was
monitored in spectroﬂuorimeter Tecan (Salzburg, Austria) with
excitation at 485 nm and emission at 530 nm. As an internal
control 50 lM of H2O2 was added to control cells under PMA-
stimulation to ensure the speciﬁcity of DCFH-DA. The results were
expressed as percentage of the control group.
2.6.5. Nitric oxide production (NO)
NO production was performed according to Ding et al. (1988)
through nitrite determination. Nitric oxide is rapidly converted into
nitrite in aqueous solutions and, therefore, the total nitrite can be
used as an indicator of nitric oxide concentration. The spectropho-
tometric analysis of the total nitrite content was performed by
using the Griess reagent (1% sulfanilic acid, 0.1% N-1-naphthyl-
ethylenediamine dihydrochloride) in supernatants. Neutrophils
(5  105/100 lL) in RPMI 1640 medium were treated with or with-
out 2 lMof astaxanthin, 100 lMof vitamin C and 20 mMof glucose
and 30 lM of MGO and stimulated with lipopolysaccharide (LPS) at
10 lg/well for 4 h. Then, the same volume of Griess (187 lL) was
added to cells and the absorbance was measured in 550 nm. The ni-
trite concentration was determined using sodium nitrite as astandard (0–60 lM). The results were expressed as percentage of
the control group.
2.6.6. Intracellular Ca2+ concentration
Changes in cytosolic Ca2+ levels were monitored by ﬂuorescence
using the calcium-sensitive probe Fura 2-AM (Otton et al., 2007).
Neutrophils (1  106/well) were treated with or without 2 lM of
astaxanthin, 100 lM of vitamin C and 30 lM of MGO in the pres-
ence of opsonized zymosan particles (1  106/well). Total intracel-
lular release of Ca2+ was monitored for 60 min in a microplate
reader (Tecan, Salzburg, Austria). Transformation of the ﬂuorescent
signal to Ca2+ (in nmol Ca2+ per minute) was performed by calibra-
tion with ionomycin (100 lM, maximum concentration) followed
by EGTA addition (60 lM, minimum concentration) according to
the Grynkiewicz equation (Grynkiewicz et al., 1985).
2.7. Antioxidant proﬁle of neutrophils
2.7.1. Antioxidant enzyme activity
To evaluate antioxidant enzyme activities as well as GSH and
GSSG content, we performed these speciﬁc assays after 24 h of cul-
ture as previously described. After this period, cells (5  106) were
harvested, centrifuged and the pellet was added with a speciﬁc
extraction buffer. Cells were then ruptured by ultrasonication in
a Vibra Cell apparatus (Connecticut, USA), centrifuged for 10 min,
10,000g at 4 C and the supernatant was used for analysis.
Superoxide dismutase (SOD), Catalase (CAT), glutathione peroxi-
dase (GPx) andglutathionereductase (GR)activitiesweredetermined
in neutrophils using a microplate reader (Tecan, Salzburg, Austria).
CAT activity was measured as described by Aebi (1984) based on
the direct decomposition of hydrogen peroxide (H2O2). SOD activity
was measured using the method described by Ewing and Janero
(1995) which involves the reduction of O2 radicals by nitroblue tet-
razolium (NBT) for 3 min. Glutathione peroxidase (Mannervik,
1985) and glutathione reductase (Carlberg and Mannervik, 1985)
activities were measured based on the oxidation of b-NADPH in the
presence of tert-butyl hydroperoxide, used as substrate.
2.7.2. GSH and GSSG content
Reduced (GSH) and oxidized (GSSG) glutathione content in neu-
trophils were measured as described by Rahman et al. (2006). The
method is based on the reaction between reduced thiol groups
(such as in GSH) with 5,5´-dithiobis-2-nitrobenzoic acid (DTNB) to
form 5-thio-2-nitrobenzoic acid (TNB), which is stoichiometrically
detected by absorbance at 412 nm. Puriﬁed GSH and GSSG (Sigma-
Aldrich) were used as standards.
2.7.3. Protein measurement
The total protein content of cells was measured by the method
of Bradford, using BSA as standard (Bradford, 1976).
2.8. Statistical analyses
All data points are presented as the mean values with standard
errors of at least three independent experiments, each one per-
formed in triplicate. The data were analyzed by one-way ANOVA
followed by the Tukey’s post-test. The software employed for sta-
tistical analysis was GraphPad Prism (version4; GraphPad Soft-
ware, San Diego, CA, USA).
3. Results
3.1. Cell membrane integrity
Cell membrane integrity was tested by using ﬂow cytometer
and propidium iodide as a probe. After 24 h of culture, none of
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These results indicate that the concentrations of MGO, glucose,
astaxanthin and vitamin C selected to evaluate the functional
parameters of neutrophils did not cause cell death (Fig. 2). Addi-
tionally, MGO, high glucose, astaxanthin and vitamin C alone did
not promote changes in cell viability (data not shown).3.2. Phagocytic capacity
In order to determine the potential of MGO and glucose to mod-
ulate the phagocytic capacity of human neutrophils, we measured
the incorporation of opsonized zymosan particles in the cells (Ta-
ble 1). There was a signiﬁcant decrease of 30% in the phagocytic
capacity of neutrophils after treatment with glucose + methylgly-
oxal (GM group), whereas there was an increase of 22% in the
phagocytic capacity after AV-treatment as compared to the control
group. When GM-treated cells were added with antioxidants
(AVGM group) we observed a complete restoration in the phago-
cytic capacity. Neither glucose nor MGO alone promoted the same
effect observed when those compounds were combined (data not
shown). Vitamin C alone promoted improvement in the phagocytic
capacity (data not shown).3.3. Myeloperoxidase (MPO) activity
MPO activity was evaluated in neutrophils after induction of
neutrophil-degranulation by addition of PMA for 30 min (Table
1). As compared with the control group, MPO activity was in-
creased by 40% in the GM-group and reduced 86% and 94% in the
AV and AVGM groups, respectively.3.4. Hypochlorous acid production
Neutrophils were stimulated to produce hypochlorous acid by
the addition of PMA (60 ng/well). Hypochlorous acid concentration
was signiﬁcantly reduced by 25% in the AV group and increased by
135% and 99% in the GM and AVGM groups, respectively, when
compared with the control group (Table 1).3.5. Glucose-6-phosphate dehydrogenase activity
The maximum G6PDH activity was assessed by the reduction of
the co-factor NADP+ into NADPH in human neutrophils (Table 1).
GM promoted a signiﬁcant reduction of 37% in G6PDH activityControl AV GM AVGM
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Fig. 2. Viability of human neutrophils (5  105/well) after 24 h of culture. Cells
were treated with glucose (20 mM) and MGO (30 lM) with or without the
antioxidants astaxanthin (2 lM) and vitamin C (100 lM), and cultured as
previously described. Afterwards, cells were harvested and then analyzed by ﬂow
cytometry using propidium iodide as a probe. Results are presented as mean ± SEM
of at least three independent experiments, each one performed in triplicate.and astaxanthin + vitamin C addition (AVGM group) increased
the G6PDH activity by 52% when compared to the GM group.
3.6. Cytokines Release
TNF-a, IL-1b, and IL-6 are inﬂammatory cytokines which play
important roles in immune responses to a variety of inﬂammatory
stimuli. Therefore, we evaluated the effects of GM on TNF-a, IL-1b,
and IL-6 after 18 h of LPS-stimulation. The levels of these cytokines
in the culture supernatants were measured using ELISA kits. Con-
trol neutrophils treated with LPS showed a signiﬁcant increase in
cytokine production when compared with the basal condition
(100 ± 10 pg/ml, data not shown). The production of pro-
inﬂammatory cytokines IL-6, IL-1b and TNF-a by human neutro-
phils in the AVGM group was signiﬁcantly decreased by 46%, 36%
and 77%, respectively, when compared with the GM-group. IL-1b
and TNF-a were also reduced in the AV-group by 42% and 89%,
respectively, when compared with the control group.3.7. Measurement of superoxide anion production
The production of reactive oxygen species is among the key
weapons used by neutrophils to exterminate pathogens. In order
to evaluate some possible modulation of MGO + glucose and asta-
xanthin and vitamin C in a few of these species we used different
probes. Superoxide anion production was measured by using two
different probes, DHE and lucigenin. As assayed by the DHE
probe, when GM-treated cells were stimulated with PMA there
was an increase of 41% in the superoxide anion production com-
pared with the PMA-control cells. Cells treated with astaxanthin
plus vitamin C decreased production of superoxide anion by
54% as compared with the control-stimulated group. Addition of
antioxidants to cells treated with GM (AVGM group) promoted
a reduction of 66% in superoxide as compared with the GM group
in stimulated conditions. Rotenone + Sodium Azide and DPI were
added to neutrophils under PMA-stimulation. Both inhibitors sig-
niﬁcantly reduced superoxide anion production to basal levels.
SOD enzyme addition was used to evaluate the speciﬁcity of
DHE probe to superoxide anion (Fig. 3A), and as expected there
was no signiﬁcant ﬂuorescence in this group. As an internal con-
trol, we also carried out the addition of 50 lM of H2O2 to PMA-
treated cells. As expected, there was no increase in the ﬂuores-
cence produced, thus ensuring the speciﬁcity of DHE for superox-
ide anion (data not shown).
The lucigenin probe (Fig. 3B) was used to measure the activa-
tion of NADPH-oxidase and then extracellular superoxide anion
production. For this purpose neutrophils were challenged with
opsonized zymosan particles. All treatments promoted a reduction
in the superoxide anion production as compared with control-
zymosan group. DPI (10 lM) addition 30 min before the treatment
with zymosan particles promoted a total inhibition in the lucigenin
signal, indicating that, indeed, superoxide anion production
occurred via NADPH-oxidase activation. Sodium azide (SA) did
not promote a signiﬁcant reduction in the lucigenin light emission,
indicating the speciﬁcity of lucigenin probe to superoxide anion
present in the extracellular compartment.3.8. Hydrogen peroxide production
Hydrogen peroxide production was evaluated by the method of
phenol red oxidation (Fig. 3C) and DCFH-DA probe (Fig. 3D).
MGO + glucose did not promote any modiﬁcation in the H2O2 pro-
duction. However, in both assays when the neutrophils were trea-
ted with the antioxidants in the AV and AVGM groups, there was a
Table 1
Functional parameters of human neutrophils.
Control AV GM AVGM
Phagocytosis (Score of phagocitic capacity) 263 ± 11 319 ± 11a 174 ± 11a 315 ± 9b
MPO activity (relative luminescence unit) 10516 ± 688 670 ± 61a 14730 ± 588a 1456 ± 106a,b
HOCl production (lM of HOCl/6  105 cells) 18.8 ± 1.22 14.1 ± 0.66a 44.2 ± 0.53a 37.5 ± 1.52a,b
G6PDH activity (nmol/min/mg/protein) 48.6 ± 5.52 42.5 ± 5.33 35.1 ± 4.05a 53.3 ± 3.34b
IL-6 (pgml1) 428 ± 71 420 ± 43 669 ± 59a 360 ± 56b
IL-1b (pgml1) 121 ± 12 71 ± 5a 103 ± 8 66 ± 5a,b
TNF-a (pgml1) 69 ± 6 8 ± 1a 53 ± 4 11 ± 1a,b
The results are presented as mean ± SEM of at least three experiments performed in triplicate. In the assay of cytokines production, all groups were LPS-stimulated and in the
myeloperoxidase assay and hypochlorous acid production, both experiments were stimulated with PMA.
a Compared to control group (p < 0.001).
b Compared to GM group (p < 0.0001).
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Fig. 3. (A) Intracellular superoxide anion production assayed by DHE probe, (B) extracellular superoxide anion production assayed by lucigenin probe, (C) hydrogen peroxide
production assayed by phenol red oxidation, and by using DCFH-DA probe (D), NO production assayed by Griess reagent (E). Neutrophils were stimulated as described in the
Material and Methods section. The results are presented as mean ± SEM of at least three independent experiments, each one performed in triplicate. (a) compared to control-
stimulated group (p < 0.0001); (b) compared to GM-stimulated group (p < 0.001); (c) compared to control non-stimulated group (p < 0.001).
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PMA-stimulation. As a positive control for the DCFH-DA probe we
added 50 lM of H2O2. Our data show that the DCFH-DA probe has a
high speciﬁcity to hydrogen peroxide.3.9. Nitric oxide production
The NO production was evaluated in cells at basal and
LPS-stimulated conditions (Fig. 3E). In basal conditions there was
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Fig. 4. Total intracellular calcium [Ca2+]i (nM) mobilization monitored during
20 min. Cells (1  106/well) were previously loaded with 5 lM Fura 2-AM for 1 h
and then incubated with glucose + MGO and/or astaxanthin + vitamin C and
stimulated with opsonized zymosan particles (5  106/well). The results are
presented as mean ± SEM of at least three independent experiments, each one
performed in triplicate.
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compared with the control group. After LPS-stimulation there
was an increase in NO production of 52% and 37% in the AV and
AVGM groups respectively, as compared with the control group.
3.10. Intracellular calcium concentration
Intracellular calcium mobilization was monitored for 20 min-
utes by using Fura 2-AM probe in neutrophils challenged with
opsonized zymosan particles (Fig. 4). There was no signiﬁcant dif-
ference in calcium release among all groups.
3.11. Activity of antioxidant enzymes
Total SOD activity was decreased in the GM and AV groups by
28% and 23%, respectively, as compared to the control group (Table
2). In the AVGM group there was an increase of 35% in the total
SOD activity in comparison with the GM group. Maximum activity
of catalase (CAT) increased in 43% in the GM group, whereas there
was a reduction of 32% and 17% in the AV and AVGM groups,
respectively, both compared with the control group. In the AVGM
treated cells we observed a reduction of 42% when compared with
the GM group. However, there was a 3-fold increase in the GPx
activity in the AVGM group compared with the control. GM and
AV reduced the GR activity in 82% and 25%, respectively, compared
to the control group, whereas in the AVGM group there was an 11-
fold increase in GR activity compared to the GM group (Table 2).
3.12. GSH and GSSG content and GSH/GSSG ratio
The content of GSH increased 93% after addition of antioxidants
in the AV group when compared with the control group. As a con-
sequence, GSH/GSSG ratio was increased in the AV group when
compared with the control group (Table 2).
4. Discussion
Diabetic patients suffer from many common infections whose
causes remain unknown. One hypothesis suggests that the damage
would be caused by immune glycation which can be responsible
for increased susceptibility to infections (Price et al., 2010). Among
the glycation agents we call attention to methylglyoxal, which is a
dicarbonyl reactive that originates from the breakdown of glucose
(Desai and Wu, 2007). The results of this study showed thatco-treatment of human neutrophils with MGO/high glucose pro-
moted important modiﬁcations in the neutrophil function
in vitro. Treatment of neutrophils with MGO/high glucose did not
promote citotoxicity; however, it reduced the phagocytic capacity
and the G6PDH, total/SOD and GR activities. Additionally, there
was an increase in the activity of myeloperoxidase (MPO) with
consequent increase in the hypochlorous acid production, CAT
activity and in the release of IL-6 cytokine without changes in
intracellular calcium mobilization. Contrasting with other studies
(Dhar et al., 2008), MGO/high glucose did not show a strong pro-
oxidant effect, as demonstrated by the ratings in the production
of superoxide anion, hydrogen peroxide and nitric oxide. These re-
sults indicate which MGO/high glucose effects did not involve oxi-
dative stress or calcium release. In addition, our study shows that
the association of astaxanthin with vitamin C greatly improved
neutrophil phagocytic capacity, decreasing all reactive oxygen spe-
cies measured, pro-inﬂammatory IL-1b and TNF-a release, MPO
activity and HClO production. The combination of astaxanthin with
vitamin C alone has more antioxidant and anti-inﬂammatory than
when they were in the presence of MGO/high glucose.
The abnormal glucose homeostasis in diabetes due to the for-
mation of the highly reactive metabolite MGO (Fleming et al.,
2011; Tajima et al., 2002; Thornalley, 2005) may be the key step
in triggering the neutrophil dysfunction. Neutrophils are the ﬁrst
immune cells to enter the site of infection or injury and there neu-
trophils kill microorganisms by ingesting them into phagocytic
vacuoles (phagosomes). Therefore, phagocytosis is undoubtedly
one of the most important roles of neutrophils. During phagocyto-
sis, granules in the cytoplasm of neutrophils merge with the newly
formed phagosome, forming the phagolysosome (Kuijpers et al.,
2001). The cytoplasmic granules of neutrophils have as one of their
main constituent myeloperoxidase, the enzyme that catalyzes the
reaction of hydrogen peroxide in the presence of halide ions such
as chloride, bromide and iodide hipohalosos acids, in particular
hypochlorous acid (Hampton et al., 1998; Kettle et al., 1997).
Hypochlorous acid is considered one of the most important anti-
microbial agents produced by neutrophils. During phagocytosis
there is activation of the NADPH oxidase, an enzyme complex that
assembles in the phagosomal membrane and converts oxygen into
the superoxide radical anion (O2). Superoxide anion is generated
in the external surface (i.e. inside the phagosome) with reducing
equivalents supplied by intracellular NADPH. During granules
secretion, phagocytosis and killing of pathogens, levels of calcium
in the cytosol are usually increased (Lee et al., 2003).
In cells co-treated with MGO/high glucose (GM group) there
was an increase in MPO enzyme activity and consequently in the
production of hypochlorous acid (Table 1), whereas neither high
glucose nor MGO alone yielded the same effect (data not shown).
Myeloperoxidase is an enzyme stored in azurophilic granules of
polymorphonuclear neutrophils and released into extracellular
ﬂuid during inﬂammatory processes. Several studies have shown
its involvement in oxidative stress and inﬂammation. Recently,
MPO has been considered as a possible marker of plaque instability
and a useful tool for the prognostic evaluation of patients with cor-
onary artery disease (Gustapane et al., 2011). Possibly, increased
release and activity of MPO in neutrophils promoted by co-treat-
ment of neutrophils with MGO/high glucose could contribute to
the development of the micro- and macro-vascular complications
observed in diabetic condition.
In contrast, cells treated with antioxidants promoted a marked
reduction in the MPO and HClO production along with a drastic
reduction in all reactive oxygen species. This effect was not
observed when cells were treated with either astaxanthin or vita-
min C alone. Superoxide is a physiological substrate for MPO and
their interactions are central to an important host defense mecha-
nism. When released by neutrophils, MPO enzyme operates in the
Table 2
Antioxidant enzyme activities and glutathione content.
Control AV GM AVGM
Total/SOD (U/mg protein) 18.48 ± 1.07 14.31 ± 0.91a 13.36 ± 0.37a 18.09 ± 0.33b,c
CAT (lmol/min/mg protein) 40.51 ± 1.18 27.47 ± 1.04a 57.95 ± 1.40a,b 33.76 ± 0.98a,b
GPx (mU/mg protein) 4.54 ± 0.79 3.30 ± 0.58 6.19 ± 0.61 13.99 ± 1.09a
GR (mU/mg protein) 31.03 ± 2.06 23.35 ± 3.09a 5.55 ± 1.23a 64.49 ± 6.17a,b
GSH (lM of GSH/mg of protein) 2.78 ± 0.37 5.66 ± 0.69a 1.13 ± 0.08 1.88 ± 0.34c
GSSG (lM of GSH/mg of protein) 0.37 ± 0.04 0.43 ± 0.03 0.24 ± 0.05 0.32 ± 0.07
GSH/GSSG (lM of GSH/mg of protein) 6.37 ± 0.81 13.11 ± 1.38a 5.25 ± 1.01 6.76 ± 1.34c
The results are presented as mean ± SEM of at least three experiments performed in triplicate.
a Compared to the control group (p < 0.001).
b Compared to the MG group (p < 0.0001).
c Compared to the AV group (p < 0.001).
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showed that superoxide has a profound inﬂuence on oxidative
reactions catalysed by MPO. It reacts directly with the enzyme to
modulate production of hypochlorous acid. Within neutrophil
phagosomes, where MPO acts by killing micro-organisms, it may
be the preferred substrate for the enzyme. Superoxide also reacts
rapidly with radicals generated by MPO forming different species.
These species are likely to be toxic and contribute to the patho-
physiological actions of MPO (Winterbourn and Kettle, 2004).
Therefore, reduced superoxide anion and hydrogen peroxide pro-
duction promoted by astaxanthin and vitamin C can be involved
in the reduced MPO and HClO production as well as a direct scav-
enger effect promoted by antioxidants.
In addition, the phagocytic capacity of neutrophils and G6PDH
activity, key enzyme of pentose pathway involved in NADPH forma-
tion, were decreased in cells after treatment with MGO/high glu-
cose. A decrease in the phagocytic capacity accompanied by a
decrease in NADPH availability could mean minor neutrophil effec-
tiveness to destroy pathogens. This fact has been associated with
the impairment in neutrophil function observed in diabetes (Lecube
et al., 2011). Decreased phagocytic capacity by induced by MGO/
high glucosewas prevented by treatment of cells with the combina-
tion of antioxidants astaxanthin and vitamin C. Previous studies
from our group also showed that addition of astaxanthin alter the
capacity of neutrophils to phagocytose opsonized zymosan parti-
cles under different conditions (Guerra and Otton, 2011; Macedo
et al., 2010; Marin et al., 2011). The mechanism by which the anti-
oxidant astaxanthin improves phagocytic capacity of neutrophils
remains to be elucidated in future studies. Although it is well
known that phagocytosis in neutrophil cells is a process which in-
volves intracellular calcium mobilization, in the present study we
did not observe any changes in intracellular calcium concentration
among all groups.
By means of Maillard reaction, MGO is able to cross-link with
cellular proteins on targeted amino acids (arginine, lysine), leading
to the formation of advanced glycation end-products (AGEs), and
thus contributing to aging and complications in chronic diseases
(Fleming et al., 2011; Thornalley, 2005). Similarly to our results,
some authors showed which MGO inactivate the enzyme glutathi-
one reductase (Paget et al., 1998; Park et al., 2003;Wu and Juurlink,
2002). Glutathione reductase recycles GSSG using NADPH as a
cofactor, reestablishing the intracellular content of reduced gluta-
thione (GSH) (Juurlink, 1999;Wu and Juurlink, 2002). Other studies
have shown that MGO reduced GSH contentmaking cells more sen-
sitive to oxidative stress (Kikuchi et al., 1999;Meister, 1988; Shinpo
et al., 2000). The inactivation of MGO is a process catalyzed by the
glyoxalase system that uses glutathione (GSH) as a cofactor. MGO
inactivated bovine glutathione peroxidase in a time and dose-
dependent manner, forming a connection with glutathione to sites
of arginine 184 and 185 (Park et al., 2003). High concentration of
MGO in plasma and aorta are associated with increased levels ofsuperoxide, signiﬁcantly reduced levels of GSH, decreased activity
of glutathione peroxidase and glutathione reductase in SHR rats
with high blood pressure (Wang et al., 2005). Contrasting with
these studies, we did not observe any change in the content of
GSH, GSSG and in the rate GSH/GSSG (Table 2).
Studies by Chang and colleagues (Chang et al., 2005) demon-
strated that MGO caused mitochondrial oxidative stress by increas-
ing the mitochondrial production of superoxide, nitric oxide and
peroxynitrite. MGO can inhibit complex III and thereby disrupt
the electron transport chain, leading to leakage of electrons to form
superoxide anion (Wang et al., 2009). The direct effect of MGO on
mitochondria was investigated by Desai and colleagues (Desai
and Wu, 2007) using MitoSOX, a mitochondrial speciﬁc probe used
to detect mitochondrial superoxide production. Incubation of ves-
sel smooth muscle cells with MGO 30 lmol/L signiﬁcantly induced
mitochondrial superoxide production as compared with the group
of untreated cells. Another study showed that incubation of vascu-
lar smoothmuscle cells (VSMCs) of rat aorta withMGO signiﬁcantly
increased production of superoxide in a dose-dependent manner,
which was prevented by the addition of enzyme superoxide dismu-
tase (SOD) or inhibition of NADPH oxidase with DPI (Chang et al.,
2005). MGO also increased the generation of hydrogen peroxide
in VSMCs and increased formation of peroxynitrite (ONOO–)
through the induction of inducible NOS (iNOS) (Chang et al.,
2005). Similar results were found byWard andMcLeish, who added
MGO in neutrophils and found that there was a signiﬁcant increase
in basal production of hydrogen peroxide and superoxide anion in a
dose-dependent manner of the MGO concentration, indicating in-
creased respiratory burst activity (Ward and McLeish, 2004). The
effect of MGO was signiﬁcantly higher in platelets pretreated with
an agent that depletes GSH and glutathione peroxidase (Leoncini
and Poggi, 1996). Contrasting with these results, our data show that
MGO/high glucose did not cause any major change in the produc-
tion of reactive oxygen/nitrogen species in neutrophils (Fig. 3).
One acceptable reason for the weak pro-oxidant effect of MGO/
high glucose could be the MGO concentration used in the present
study. Many authors demonstrate a modulation of MGO on differ-
ent cell types using highMGO concentrations ranging from 100 lM
to 1 mM (Chang et al., 2005; Desai et al., 2010; Wang et al., 2009).
We used MGO at 30 lM, which is considered by some authors a
high concentration usually found in the diabetic plasma (Dutra
et al., 2005). In addition, the incubation time of neutrophils which
MGO/high glucose could be short to promote any permanent mod-
iﬁcation in the neutrophil function. Several authors have shown
that, to be effective as a glycation agent, MGO needs to be incu-
bated for long periods, which was not observed in this work, due
to the short half-life of neutrophils in culture.
On the other hand, association of astaxanthin with vitamin C
promoted a clear antioxidant effect (Fig. 3) as observed by the
marked reduction in the production of superoxide anion and
hydrogen peroxide production. Compared with a previous study
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(Bolin et al., 2010; Campoio et al., 2011; Guerra and Otton, 2011;
Macedo et al., 2010), the association of both antioxidants allowed
a great antioxidant action. Many authors have reported the
effective antioxidant action of either astaxanthin or vitamin C
alone, but not in combination. In our model, the astaxanthin/vita-
min C system mimics the recycling system of vitamin C/vitamin E.
Astaxanthin provides cell membranes with potent protection
against free radicals or other oxidative attack. Experimental studies
conﬁrm that this nutrient has a large capacity to neutralize free
radicals or other oxidant activity in the nonpolar (‘‘hydrophobic’’)
zones of phospholipid aggregates, as well as along their polar
(hydrophilic) boundary zones (Fassett and Coombes, 2011).
Vitamin C, in turn, promotes antioxidant effects mainly in water-
phase microenvironment.
Neutrophils are capable of expressing a variety of proteins
involved in inﬂammation and immune responses, including
cytokines such as IL-1b, IL-1ra (interleukin receptor antagonist),
IL-8, IL-12, TNF-a, TGF -b, MIP-1a, MIP-1b, GM-CSF and IFN-a
(Scapini et al., 2000). Although cytokines induce pathology when
expressed inappropriately, they play important roles in a variety
of physiological processes. Wang and colleagues demonstrated
that 30 lmol/L MGO for 12 h signiﬁcantly increased the secretion
of pro-inﬂammatory cytokines such as interleukin-6 (IL-6), IL-8
and tumor necrosis factor (TNF-a), and induced apoptosis in neu-
trophils (Wang et al., 2007). In this study, MGO/high glucose in-
creased IL-6 production in cells stimulated with LPS. When
antioxidants were added to MGO/high glucose treated cells (AVGM
group), there was an important reduction in all pro-inﬂammatory
cytokines when compared to the GM group.
In summary, our results show that treatment of neutrophils
with high glucose and MGO promotes an injury to the function
of neutrophils, and this process appears not to involve oxidative
stress or calcium release. In addition, when cells were treated with
the association of antioxidants astaxanthin and vitamin C, we ob-
served a signiﬁcant improvement in the function of neutrophils
and in the redox status. The use of antioxidants to prevent or re-
verse diabetic complications seems to be necessary; however, a
single substance cannot achieve this effect. Therefore, we are pro-
posing a combination of two substances that act differently in cell
microenvironment, working in a collaborative way. The collabora-
tive way in which the antioxidants work was evidenced in almost
all experiments performed as compared with cells treated with
antioxidants alone. In the near future, the combination of antioxi-
dants astaxanthin and vitamin C might act as an adjuvant therapy
for the treatment of a variety of diseases, including diabetes melli-
tus. The answer to the question of whether the in vitro neutrophils
protection achieved by this combination of therapy can be trans-
lated to subjects with diabetes will have to wait until completion
of the ongoing clinical trial.Conﬂict of interest statement
All the authors of the present manuscript declare that there is
no any actual or potential conﬂict of interest including any ﬁnan-
cial, personal or other relationships with other people or organiza-
tions that could inappropriately inﬂuence, or be perceived to
inﬂuence our work.Acknowledgements
The authors are grateful to the technical assistance of T.R. Cam-
poio, Marinovic MP and A.C. Morandi. This research was supported
by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP
09/14382-7 and 09/17381-1), Conselho Nacional de Desenvolvimen-to Cientíﬁco e Tecnológico (Bolsa Produtividade em Pesquisa, Nivel
2, #312190/2009-3, CNPq, Brazil) and Universidade Cruzeiro do Sul.References
Aebi, H., 1984. Catalase in vitro. Methods Enzymol. 105, 121–126.
Bolin, A.P., Macedo, R.C., Marin, D.P., Barros, M.P., Otton, R., 2010. Astaxanthin
prevents in vitro auto-oxidative injury in human lymphocytes. Cell Biol. Toxicol.
26, 457–467.
Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem. 72, 248–254.
Brandt, R., Keston, A.S., 1965. Synthesis of diacetyldichloroﬂuorescin: a stable
reagent for ﬂuorometric analysis. Anal. Biochem. 11, 6–9.
Brownlee, M., 1995. Advanced protein glycosylation in diabetes and aging. Annu.
Rev. Med. 46, 223–234.
Campoio, T.R., Oliveira, F.A., Otton, R., 2011. Oxidative stress in human lymphocytes
treated with fatty acid mixture: role of carotenoid astaxanthin. Toxicol. in Vitro
25, 1448–1456.
Carlberg, I., Mannervik, B., 1985. Glutathione reductase. Methods Enzymol. 113,
484–490.
Chang, T., Wang, R., Wu, L., 2005. Methylglyoxal-induced nitric oxide and
peroxynitrite production in vascular smooth muscle cells. Free Radic. Biol.
Med. 38, 286–293.
Chew, B.P., Park, J.S., Wong, M.W., Wong, T.S., 1999. A comparison of the anticancer
activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice
in vivo. Anticancer Res. 19, 1849–1853.
Costa Rosa, L.F., Curi, R., Murphy, C., Newsholme, P., 1995. Effect of adrenaline and
phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of
pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for
cyclic AMP-dependent protein kinase mediated inhibition of glucose-6-
phosphate dehydrogenase and activation of NADP+-dependent ‘malic’
enzyme. Biochem. J. 310 (Pt 2), 709–714.
Crow, J.P., 1997. Dichlorodihydroﬂuorescein and dihydrorhodamine 123 are
sensitive indicators of peroxynitrite in vitro: implications for intracellular
measurement of reactive nitrogen and oxygen species. Nitric Oxide 1, 145–157.
Desai, K., Wu, L., 2007. Methylglyoxal and advanced glycation endproducts: new
therapeutic horizons? Recent Pat Cardiovasc Drug Discov 2, 89–99.
Desai, K.M., Chang, T., Wang, H., Banigesh, A., Dhar, A., Liu, J., Untereiner, A., Wu, L.,
2010. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can. J.
Physiol. Pharmacol. 88, 273–284.
Dhar, A., Desai, K., Kazachmov, M., Yu, P., Wu, L., 2008. Methylglyoxal production in
vascular smooth muscle cells from different metabolic precursors. Metabolism
57, 1211–1220.
Ding, A.H., Nathan, C.F., Stuehr, D.J., 1988. Release of reactive nitrogen intermediates
and reactive oxygen intermediates from mouse peritoneal macrophages.
Comparison of activating cytokines and evidence for independent production.
J. Immunol. 141, 2407–2412.
Dutra, F., Ciriolo, M.R., Calabrese, L., Bechara, E.J., 2005. Aminoacetone induces
oxidative modiﬁcation to human plasma ceruloplasmin. Chem. Res. Toxicol. 18,
755–760.
Dypbukt, J.M., Bishop, C., Brooks, W.M., Thong, B., Eriksson, H., Kettle, A.J., 2005. A
sensitive and selective assay for chloramine production by myeloperoxidase.
Free Radic. Biol. Med. 39, 1468–1477.
Ewing, J.F., Janero, D.R., 1995. Microplate superoxide dismutase assay employing a
nonenzymatic superoxide generator. Anal. Biochem. 232, 243–248.
Fassett, R.G., Coombes, J.S., 2011. Astaxanthin: a potential therapeutic agent in
cardiovascular disease. Mar Drugs 9, 447–465.
Fialkow, L., Wang, Y., Downey, G.P., 2007. Reactive oxygen and nitrogen species as
signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 42,
153–164.
Fleming, S.T., Love, M.M., Bennett, K., 2011. Diabetes and cancer screening rates
among Appalachian and non-Appalachian residents of Kentucky. J. Am. Board
Fam. Med. 24, 682–692.
Fukuzawa, K., Inokami, Y., Tokumura, A., Terao, J., Suzuki, A., 1998. Rate constants
for quenching singlet oxygen and activities for inhibiting lipid peroxidation of
carotenoids and alpha-tocopherol in liposomes. Lipids 33, 751–756.
Gebska, A., Olszanecki, R., Korbut, R., 2005. Endotoxaemia in rats: role of leukocyte
sequestration in rapid pulmonary nitric oxide synthase-2 expression. J. Physiol.
Pharmacol. 56, 299–311.
Goldschmidt, M.C., 1991. Reduced bactericidal activity in neutrophils from
scorbutic animals and the effect of ascorbic acid on these target bacteria
in vivo and in vitro. Am. J. Clin. Nutr. 54, 1214S–1220S.
Grynkiewicz, G., Poenie, M., Tsien, R.Y., 1985. A new generation of Ca2+ indicators
with greatly improved ﬂuorescence properties. J. Biol. Chem. 260, 3440–3450.
Guaiquil, V.H., Vera, J.C., Golde, D.W., 2001. Mechanism of vitamin C inhibition of
cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J.
Biol. Chem. 276, 40955–40961.
Guerra, B.A., Otton, R., 2011. Impact of the carotenoid astaxanthin on phagocytic
capacity and ROS/RNS production of human neutrophils treated with free fatty
acids and high glucose. Int. Immunopharmacol. 11, 2220–2226.
Gustapane, M., Cardillo, M.T., Biasillo, G., Biasucci, L.M., 2011. Myeloperoxidase as
possible diagnostic and prognostic marker of acute coronary syndrome. Recenti
Prog. Med. 102, 447–450.
1190 B.A. Guerra et al. / Toxicology in Vitro 26 (2012) 1181–1190Hampton, M.B., Kettle, A.J., Winterbourn, C.C., 1998. Inside the neutrophil
phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007–
3017.
Hatanaka, E., Levada-Pires, A.C., Pithon-Curi, T.C., Curi, R., 2006. Systematic study on
ROS production induced by oleic, linoleic, and gamma-linolenic acids in human
and rat neutrophils. Free Radic. Biol. Med. 41, 1124–1132.
Hussein, G., Sankawa, U., Goto, H., Matsumoto, K., Watanabe, H., 2006. Astaxanthin,
a carotenoid with potential in human health and nutrition. J. Nat. Prod. 69, 443–
449.
Juurlink, B.H., 1999. Management of oxidative stress in the CNS: the many roles of
glutathione. Neurotox. Res. 1, 119–140.
Jyonouchi, H., Sun, S., Iijima, K., Gross, M.D., 2000. Antitumor activity of astaxanthin
and its mode of action. Nutr. Cancer 36, 59–65.
Kalapos, M.P., 1999. Methylglyoxal in living organisms: chemistry, biochemistry,
toxicology and biological implications. Toxicol. Lett. 110, 145–175.
Kettle, A.J., Gedye, C.A., Winterbourn, C.C., 1997. Mechanism of inactivation of
myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem. J. 321 (Pt 2),
503–508.
Kidd, P., 2011. Astaxanthin, cell membrane nutrient with diverse clinical beneﬁts
and anti-aging potential. Altern. Med. Rev. 16, 355–364.
Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z., Miyata, T., Tashiro, K., 1999.
Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical
neurons: synergism between glycation and oxidative stress, possibly involved
in neurodegenerative diseases. J. Neurosci. Res. 57, 280–289.
Kishimoto, Y., Tani, M., Uto-Kondo, H., Iizuka, M., Saita, E., Sone, H., Kurata, H.,
Kondo, K., 2010. Astaxanthin suppresses scavenger receptor expression and
matrix metalloproteinase activity in macrophages. Eur. J. Nutr. 49, 119–126.
Kleinert, H., Pautz, A., Linker, K., Schwarz, P.M., 2004. Regulation of the expression of
inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255–266.
Kuijpers, T.W., van den Berg, J.M., Tool, A.T., Roos, D., 2001. The impact of platelet-
activating factor (PAF)-like mediators on the functional activity of neutrophils:
anti-inﬂammatory effects of human PAF-acetylhydrolase. Clin. Exp. Immunol.
123, 412–420.
Lecube, A., Pachon, G., Petriz, J., Hernandez, C., Simo, R., 2011. Phagocytic activity is
impaired in type 2 diabetes mellitus and increases after metabolic
improvement. PLoS One 6, e23366.
Lee, W.L., Harrison, R.E., Grinstein, S., 2003. Phagocytosis by neutrophils. Microbes
Infect. 5, 1299–1306.
Leoncini, G., Poggi, M., 1996. Effects of methylglyoxal on platelet hydrogen peroxide
accumulation, aggregation and release reaction. Cell Biochem. Funct. 14, 89–95.
Macedo, R.C., Bolin, A.P., Marin, D.P., Otton, R., 2010. Astaxanthin addition improves
human neutrophils function: in vitro study. Eur. J. Nutr. 49, 447–457.
Maeng, H.G., Lim, H., Jeong, Y.J., Woo, A., Kang, J.S., Lee, W.J., Hwang, Y.I., 2009.
Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not
recapitulate in vivo vitamin C effects. Immunobiology 214, 311–320.
Mannervik, B., 1985. Glutathione peroxidase. Methods Enzymol. 113, 490–495.
Marin, D.P., Bolin, A.P., Macedo Rde, C., Sampaio, S.C., Otton, R., 2011. ROS
production in neutrophils from alloxan-induced diabetic rats treated in vivo
with astaxanthin. Int. Immunopharmacol. 11, 103–109.
Mattei, R., Polotow, T.G., Vardaris, C.V., Guerra, B.A., Leite, J.R., Otton, R., Barros, M.P.,
2011. Astaxanthin limits ﬁsh oil-related oxidative insult in the anterior
forebrain of Wistar rats: putative anxiolytic effects? Pharmacol. Biochem.
Behav. 99, 349–355.
Meister, A., 1988. Glutathione metabolism and its selective modiﬁcation. J. Biol.
Chem. 263, 17205–17208.
Myzak, M.C., Carr, A.C., 2002. Myeloperoxidase-dependent caspase-3 activation and
apoptosis in HL-60 cells: protection by the antioxidants ascorbate and
(dihydro)lipoic acid. Redox Rep. 7, 47–53.
Naguib, Y.M., 2000. Antioxidant activities of astaxanthin and related carotenoids. J.
Agric. Food Chem. 48, 1150–1154.
Otton, R., da Silva, D.O., Campoio, T.R., Silveira, L.R., de Souza, M.O., Hatanaka, E.,
Curi, R., 2007. Non-esteriﬁed fatty acids and human lymphocyte death: a
mechanism that involves calcium release and oxidative stress. J. Endocrinol.
195, 133–143.
Otton, R., Marin, D.P., Bolin, A.P., Santos Rde, C., Polotow, T.G., Sampaio, S.C., de
Barros, M.P., 2010. Astaxanthin ameliorates the redox imbalance in
lymphocytes of experimental diabetic rats. Chem. Biol. Interact. 186, 306–315.
Otton, R., Marin, D.P., Bolin, A.P., de Cassia Santos Macedo, R., Campoio, T.R., Fineto,
C., Jr., Guerra, B.A., Leite, J.R., Barros, M.P., Mattei, R., 2011. Combined ﬁsh oil and
astaxanthin supplementation modulates rat lymphocyte function. Eur. J. Nutr.
epub ahead of print.
Paget, C., Lecomte, M., Ruggiero, D., Wiernsperger, N., Lagarde, M., 1998.
Modiﬁcation of enzymatic antioxidants in retinal microvascular cells by
glucose or advanced glycation end products. Free Radic. Biol. Med. 25, 121–129.Park, Y.S., Koh, Y.H., Takahashi, M., Miyamoto, Y., Suzuki, K., Dohmae, N., Takio, K.,
Honke, K., Taniguchi, N., 2003. Identiﬁcation of the binding site of
methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione
peroxidase activity via binding to glutathione binding sites Arg 184 and 185.
Free Radic. Res. 37, 205–211.
Pick, E., Mizel, D., 1981. Rapid microassays for the measurement of superoxide and
hydrogen peroxide production by macrophages in culture using an automatic
enzyme immunoassay reader. J. Immunol. Methods 46, 211–226.
Price, C.L., Hassi, H.O., English, N.R., Blakemore, A.I., Stagg, A.J., Knight, S.C., 2010.
Methylglyoxal modulates immune responses: relevance to diabetes. J. Cell Mol.
Med. 14, 1806–1815.
Rahman, I., Kode, A., Biswas, S.K., 2006. Assay for quantitative determination of
glutathione and glutathione disulﬁde levels using enzymatic recycling method.
Nat. Protoc. 1, 3159–3165.
Sampaio, S.C., Sousa-e-Silva, M.C., Borelli, P., Curi, R., Cury, Y., 2001. Crotalus
durissus terriﬁcus snake venom regulates macrophage metabolism and
function. J. Leukoc. Biol. 70, 551–558.
Savenkova, M.L., Mueller, D.M., Heinecke, J.W., 1994. Tyrosyl radical generated by
myeloperoxidase is a physiological catalyst for the initiation of lipid
peroxidation in low density lipoprotein. J. Biol. Chem. 269, 20394–20400.
Scapini, P., Lapinet-Vera, J.A., Gasperini, S., Calzetti, F., Bazzoni, F., Cassatella, M.A.,
2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177,
195–203.
Schmidt, A.M., Hasu, M., Popov, D., Zhang, J.H., Chen, J., Yan, S.D., Brett, J., Cao, R.,
Kuwabara, K., Costache, G., et al., 1994. Receptor for advanced glycation end
products (AGEs) has a central role in vessel wall interactions and gene
activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA
91, 8807–8811.
Sheppard, F.R., Kelher, M.R., Moore, E.E., McLaughlin, N.J., Banerjee, A., Silliman, C.C.,
2005. Structural organization of the neutrophil NADPH oxidase:
phosphorylation and translocation during priming and activation. J. Leukoc.
Biol. 78, 1025–1042.
Shinpo, K., Kikuchi, S., Sasaki, H., Ogata, A., Moriwaka, F., Tashiro, K., 2000. Selective
vulnerability of spinal motor neurons to reactive dicarbonyl compounds,
intermediate products of glycation, in vitro: implication of inefﬁcient
glutathione system in spinal motor neurons. Brain Res. 861, 151–159.
Sies, H., Stahl, W., 1995. Vitamins E and C, beta-carotene, and other carotenoids as
antioxidants. Am. J. Clin. Nutr. 62, 1315S–1321S.
Tajima, K., Hosokawa, K., Yoshida, Y., Dantes, A., Sasson, R., Kotsuji, F., Amsterdam,
A., 2002. Establishment of FSH-responsive cell lines by transfection of pre-
ovulatory human granulosa cells with mutated p53 (p53val135) and Ha-ras
genes. Mol. Hum. Reprod. 8, 48–57.
Takedo, A., Yasuda, T., Miyata, T., Mizuno, K., Li, M., Yoneyama, S., Horie, K., Maeda,
K., Sobue, G., 1996. Immunohistochemical study of advanced glycation end
products in aging and Alzheimer’s disease brain. Neurosci. Lett. 221, 17–20.
Thornalley, P.J., 2005. Measurement of protein glycation, glycated peptides, and
glycation free adducts. Perit. Dial. Int. 25, 522–533.
Turk, Z., 2010. Glycotoxines, carbonyl stress and relevance to diabetes and its
complications. Physiol. Res. 59, 147–156.
Vissers, M.C., Wilkie, R.P., 2007. Ascorbate deﬁciency results in impaired neutrophil
apoptosis and clearance and is associated with up-regulation of hypoxia-
inducible factor 1alpha. J. Leukoc. Biol. 81, 1236–1244.
Wang, Y., Russo, T.A., Kwon, O., Chanock, S., Rumsey, S.C., Levine, M., 1997.
Ascorbate recycling in human neutrophils: induction by bacteria. Proc Natl
Acad Sci U S A 94, 13816–13819.
Wang, X., Desai, K., Chang, T., Wu, L., 2005. Vascular methylglyoxal metabolism and
the development of hypertension. J. Hypertens. 23, 1565–1573.
Wang, H., Meng, Q.H., Gordon, J.R., Khandwala, H., Wu, L., 2007. Proinﬂammatory
and proapoptotic effects of methylglyoxal on neutrophils from patients with
type 2 diabetes mellitus. Clin. Biochem. 40, 1232–1239.
Wang, H., Liu, J., Wu, L., 2009. Methylglyoxal-induced mitochondrial dysfunction in
vascular smooth muscle cells. Biochem. Pharmacol. 77, 1709–1716.
Ward, R.A., McLeish, K.R., 2004. Methylglyoxal: a stimulus to neutrophil oxygen
radical production in chronic renal failure? Nephrol. Dial. Transplant. 19, 1702–
1707.
Winterbourn, C.C., Kettle, A.J., 2004. Reactions of superoxide with myeloperoxidase
and its products. Jpn. J. Infect. Dis. 57, S31–33.
Wu, L., Juurlink, B.H., 2002. Increased methylglyoxal and oxidative stress in
hypertensive rat vascular smooth muscle cells. Hypertension 39, 809–814.
Yuan, J.P., Peng, J., Yin, K., Wang, J.H., 2011. Potential health-promoting effects of
astaxanthin: a high-value carotenoid mostly from microalgae. Mol. Nutr. Food
Res. 55, 150–165.
